Neutrophil-lymphocyte ratio predicts response to chemotherapy in triple-negative breast cancer.

about

Neutrophil-lymphocyte ratio predicts response to chemotherapy in triple-negative breast cancer.

Item

http://www.wikidata.org/entity/Q53069534

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Neutrophil-lymphocyte ratio pr ...... triple-negative breast cancer.

@en

Neutrophil-lymphocyte ratio pr ...... triple-negative breast cancer.

@nl

type

Item

label

Neutrophil-lymphocyte ratio pr ...... triple-negative breast cancer.

@en

Neutrophil-lymphocyte ratio pr ...... triple-negative breast cancer.

@nl

prefLabel

Neutrophil-lymphocyte ratio pr ...... triple-negative breast cancer.

@en

Neutrophil-lymphocyte ratio pr ...... triple-negative breast cancer.

@nl

P1476

Neutrophil-lymphocyte ratio pr ...... triple-negative breast cancer.

@en

P2093

E K Kim

http://www.w3.org/2001/XMLSchema#string

E Kang

http://www.w3.org/2001/XMLSchema#string

H J Kim

http://www.w3.org/2001/XMLSchema#string

J H Kim

http://www.w3.org/2001/XMLSchema#string

K M Kang

http://www.w3.org/2001/XMLSchema#string

S Chae

http://www.w3.org/2001/XMLSchema#string

S H Kim

http://www.w3.org/2001/XMLSchema#string

S W Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and cancer

Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer.

Exocytosis of azurophil and arginase 1-containing granules by activated polymorphonuclear neutrophils is required to inhibit T lymphocyte proliferation.

Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms.

Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients

Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy.

P304

e113-e119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3747/CO.25.3888

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

So Yeon Park

P577

2018-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29719435

http://www.w3.org/2001/XMLSchema#string

P932

5927790

http://www.w3.org/2001/XMLSchema#string